pCDH-Neo/Myc PD-L1 Citations (1)
Originally described in: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. PubMed Journal
Articles Citing pCDH-Neo/Myc PD-L1
| Articles |
|---|
| An Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System. Shang Y, Li S, Xu T, Sun Y, Li F. Cancer Res. 2025 Nov 14;85(22):4315-4328. doi: 10.1158/0008-5472.CAN-25-0809. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.